HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
申请人:Rodgers James D.
公开号:US20110059951A1
公开(公告)日:2011-03-10
The present invention provides heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines, as well as their compositions and methods of use, that modulate the activity of Janus kinases (JAKs) and are useful in the treatment of diseases related to the activity of JAKs including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
本发明提供了吡唑-4-基-吡咯[2,3-d]嘧啶的杂环衍生物,以及它们的组合物和使用方法,可以调节Janus激酶(JAKs)的活性,并且在治疗与JAKs活性相关的疾病方面有用,例如炎症性疾病、自身免疫性疾病、癌症和其他疾病。